معرفی
Catharina Svanborg is a Professor of Clinical Immunology at Lund University and a Senior/Chief Physician at Lund University Hospital and Skåne University Hospital. She is also the founder of HAMLET Pharma AB, a company focused on tumoricidal protein complexes, and serves as a Director of Medivir AB and HAMLET Pharma AB.
- PhD (University of Göteborg, Sweden, 1978; conflicting source mentions University of Michigan)
- MD (University of Gothenburg, Sweden, 1974)
Her research spans microbiology, innate immunity, and HAMLET, a complex of alpha-lactalbumin and oleic acid with therapeutic effects on tumors. She has authored over 400 papers and holds leadership roles in organizations like the Royal Swedish Academy of Engineering Sciences (IVA) and the Swedish Cancer Society (PkC).
Key scientific contributions include elucidating the molecular mechanisms of HAMLET, studying microbial pathogenesis in urinary tract infections, and exploring the anti-cancer properties of human milk proteins.
- Awards: Member of the Royal Swedish Academy of Sciences, Member of Academia Europaea
- Leadership roles: Board member of IVA, Director of Medivir AB, Scientific Advisory Board of NatImmune A/S
